Investment
Features
FeesSafety
Academy
More
Pluang+

BlackRock's stake in Fagron drops below 3% after share transfers, holding 2.96% voting rights as of October 2026.

Market News
16 Oct 2026
Na
View Source
Neutral
BlackRock's stake in Fagron drops below 3% after share transfers, holding 2.96% voting rights as of October 2026.

BlackRock, Inc. disclosed that its voting rights in pharmaceutical company Fagron NV fell below the 3% reporting threshold due to the transfer of voting securities, despite acquiring financial instruments equivalent to voting rights. As of October 12, 2026, BlackRock holds 2,015,779 voting shares and 166,184 equivalent financial instruments, totaling 2,181,963 voting rights or 2.96% of Fagron's outstanding voting rights. This notification complies with Belgian transparency laws and reflects BlackRock's adjusted stake across multiple subsidiaries. Investors can review full disclosures on Fagron's website. The change may influence shareholder dynamics but does not indicate a major shift in control.

The disclosure of BlackRock, Inc.'s voting rights in Fagron NV provides context for readers. For those following health-sector stocks, here is Pluang's market snapshot as of Oct 16, 2026 23:21 WIB: out of 150 priced US health-sector stocks, 36 rose and 114 fell. Notable movers include IBRX at USD 9.37 with a 1-day change of -6.30% and balanced Pluang order activity, TMDX at USD 71.75 down 6.23% with 64% sell orders, and ABCL at USD 11.89 down 6.23% but with 81% buy orders and a typical hold time of 41 days.

More News

FDA approves phentolamine eye drops for presbyopia, offering a new treatment for age-related near vision loss.

FDA approves phentolamine eye drops for presbyopia, offering a new treatment for age-related near vision loss.

Opus Genetics announced FDA approval of phentolamine ophthalmic solution 0.75% for treating presbyopia, an age-related condition affecting near vision in adults. This approval, based on successful Phase 3 trials, provides a non-invasive option that i...

Market News
Bullish
23 minutes ago
K2 Vision performs 5,000 Light Adjustable Lens procedures, leading globally in this advanced vision tech.

K2 Vision performs 5,000 Light Adjustable Lens procedures, leading globally in this advanced vision tech.

K2 Vision has completed over 5,000 procedures using the Light Adjustable Lens (LAL), making it the highest-volume practice worldwide for this technology. The LAL is unique because it can be adjusted after implantation to fine-tune vision based on the...

Market News
Bullish
23 minutes ago
BlackRock's stake in Fagron falls below 3% after share disposals, now holding 2.96% voting rights.

BlackRock's stake in Fagron falls below 3% after share disposals, now holding 2.96% voting rights.

BlackRock, Inc. disclosed that its shareholding in Fagron NV dropped below the 3% threshold to 2.96% after selling some voting securities, despite acquiring equivalent financial instruments. As of October 12, 2026, BlackRock holds 2,015,779 voting ri...

Market News
Neutral
23 minutes ago
Meridian International Center names 25 leaders shaping U.S. global influence across sectors in 2026 cohort

Meridian International Center names 25 leaders shaping U.S. global influence across sectors in 2026 cohort

Meridian International Center announced its inaugural New Architects of American Influence cohort, recognizing 25 leaders from business, technology, culture, sports, and government who are shaping U.S. global influence. The 2026 cohort includes leade...

Market News
Bullish
30 minutes ago
M&T Bank beats Q3 2026 earnings and revenue estimates with strong loan and deposit growth.

M&T Bank beats Q3 2026 earnings and revenue estimates with strong loan and deposit growth.

M&T Bank reported adjusted earnings per share of $5.08 and revenue of $2.55 billion for Q3 2026, both surpassing analyst estimates. This marks the fourth consecutive quarter the bank has exceeded earnings and revenue expectations, reflecting consiste...

Company Fundamentals
Bullish
1 hour ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App